XML 364 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Option and Appreciation Rights Activity
The following is a summary of stock options and stock appreciation rights activity under the 2015 Plan and the 2005 Plan for the year ended December 31, 2020:
 2015 Plan2005 Plan
 Stock OptionsWeighted-
Average
Exercise
Price
Stock
Options
Weighted-
Average
Exercise
Price
Outstanding at January 1, 20203,388,750 $35.64 501,780 $64.19 
Granted3,363,766 $38.01 — $— 
Exercised(1,025,025)$31.39 (264,265)$45.89 
Canceled(307,028)$33.51 (23,329)$51.92 
Outstanding at December 31, 20205,420,463 $38.05 214,186 $88.11 
Shares exercisable at December 31, 2020878,488 $71.27 214,186 $88.11 
Shares available for grant at December 31, 20202,473,916 
Schedule of Assumptions Used in Estimation of Fair Value of Stock
 202020192018
Weighted average Black-Scholes fair value of stock
options and SARs granted
$80.48$4.98$34.80
Risk-free interest rate
0.2%-1.5%
1.5%-2.6%
2.3%-3.1%
Dividend yield—%—%—%
Volatility
116.0%-152.2%
105.4%-134.1%
93.3%-115.6%
Expected term (in years)
3.9-7.6
3.9-7.5
4.1-7.5
The ESPP is considered compensatory for financial reporting purposes. As such, the fair value of ESPP shares was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
 202020192018
Range of Black-Scholes fair values of ESPP
shares granted
$2.57-$92.67
$2.57-$35.00
$7.20-$70.64
Risk-free interest rate
0.2%-2.6%
1.2%-2.6%
0.7%-2.2%
Dividend yield—%—%—%
Volatility
66.6%-189.7%
52.2%-171.6%
52.2%-203.8%
Expected term (in years)
0.5-2.0
0.5-2.0
0.5-2.0
Schedule of Restricted Stock Units Activity
The following is a summary of restricted stock units activity for the year ended December 31, 2020:
 Number of
Shares
Per Share
Weighted-
Average
Fair Value
Outstanding and Unvested at January 1, 20201,102,311 $5.95 
Restricted stock units granted837,896 94.74 
Restricted stock units vested(840,812)9.37 
Restricted stock units forfeited(54,415)40.37 
Outstanding and Unvested at December 31, 20201,044,980 $72.59 
Schedule of Stock-Based Compensation Expense
The Company recorded stock-based compensation expense for awards issued under the above mentioned plans in the consolidated statements of operations as follows (in thousands):
Year Ended December 31,
202020192018
Research and development$55,955 $8,436 $10,575 
General and administrative72,080 8,612 7,739 
Total stock-based compensation expense$128,035 $17,048 $18,314